Final Cut Express
Final Cut Express[edit | edit source]
Final Cut Express was a non-linear video editing software created by Apple Inc. It was a "prosumer" version of Final Cut Pro, offering a more affordable option for video editing enthusiasts and semi-professional filmmakers. Final Cut Express was discontinued in 2011.
History[edit | edit source]
Final Cut Express was first released in 2003 as a more accessible version of Final Cut Pro, which was already a popular choice among professional video editors. The software was designed to provide a balance between the advanced features of Final Cut Pro and the simplicity of iMovie, Apple's consumer-level video editing software.
Features[edit | edit source]
Final Cut Express offered many of the core features of Final Cut Pro, including:
- **Non-linear editing**: Users could edit video in a non-destructive manner, allowing for greater flexibility and creativity.
- **Multicam editing**: This feature allowed users to edit footage from multiple cameras simultaneously.
- **Advanced effects and transitions**: Final Cut Express included a variety of built-in effects and transitions, as well as support for third-party plugins.
- **Keyframe animation**: Users could animate video and audio effects over time using keyframes.
- **Support for multiple formats**: The software supported a wide range of video formats, including DV, HDV, and AVCHD.
Discontinuation[edit | edit source]
In June 2011, Apple announced that it would discontinue Final Cut Express. This decision was made as part of a broader strategy to streamline its video editing software offerings. Apple introduced Final Cut Pro X as the successor to Final Cut Pro, incorporating many features that appealed to both professional and amateur editors. As a result, Final Cut Express was phased out, and users were encouraged to transition to either iMovie or Final Cut Pro X.
Legacy[edit | edit source]
Despite its discontinuation, Final Cut Express remains a significant part of Apple's history in video editing software. It served as a bridge for many users who wanted more advanced features than iMovie offered but were not ready to invest in the full version of Final Cut Pro. The software's influence can still be seen in the features and design of Final Cut Pro X.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
